@doctorconnor Check out the supplementary info in this paper. It’s my labmate’s paper and has data on over expressing gltscr1/1l which are subunits of the gbaf sub-complex in prostate cancer. https://t.co/VeEWOwpGI5

The previous BRD9&PCa paper looked at whether it could be targeted in CRPC. https://t.co/QgRbmJh0Ff The authors found that BRD9 is required for the viability of prostate cancer cell lines in vitro and for optimal xenograft tumour growth in vivo [5/1

The authors of "BRD9 is a critical regulator of androgen receptor…" (https://t.co/a0yNCLA3IV) included RRIDs in their paper! We appreciate the author's support of reproducibility. #accelerateopenscience #OpenScience

Advanced #ProstateCancers that are resistant to #AndrogenReceptor antagonists are still susceptible to non-toxic BRD9 inhibitors, making them a promising alternative for halting AR signaling in progressed disease. @DrDhimanA @emilydykhuizen https://t.co/

BRD9 Is a Critical Regulator of Androgen Receptor Signaling and Prostate Cancer Progression https://t.co/vItpzXAdY6

RT @CaP_pubs: BRD9 is a critical regulator of androgen receptor signaling and prostate cancer progression. 𝘾𝙖𝙣𝙘𝙚𝙧 𝙧𝙚𝙨. #ProstateCancer ht…

BRD9 is a critical regulator of androgen receptor signaling and prostate cancer progression. 𝘾𝙖𝙣𝙘𝙚𝙧 𝙧𝙚𝙨. #ProstateCancer https://t.co/LtDl7ObNsL

RT @CR_AACR: Advanced #ProstateCancers that are resistant to #AndrogenReceptor antagonists are still susceptible to non-toxic BRD9 inhibito…

Advanced #ProstateCancers that are resistant to #AndrogenReceptor antagonists are still susceptible to non-toxic BRD9 inhibitors, making them a promising alternative for halting AR signaling in progressed disease. @DrDhimanA @emilydykhuizen https://t.co/

RT @EmilyDykhuizen: Aktan's big paper on BRD9 in prostate cancer is finally published in @CR_AACR! In the past year, Aktan graduated, submi…

RT @EmilyDykhuizen: Aktan's big paper on BRD9 in prostate cancer is finally published in @CR_AACR! In the past year, Aktan graduated, submi…

RT @EmilyDykhuizen: Aktan's big paper on BRD9 in prostate cancer is finally published in @CR_AACR! In the past year, Aktan graduated, submi…

We rarely know the stories behind the papers we read. Thank you @EmilyDykhuizen for putting it down eloquently and Aktan, I am so proud of you!

RT @EmilyDykhuizen: Aktan's big paper on BRD9 in prostate cancer is finally published in @CR_AACR! In the past year, Aktan graduated, submi…

Aktan's big paper on BRD9 in prostate cancer is finally published in @CR_AACR! In the past year, Aktan graduated, submitted the paper during the shutdown, and busted his hump on revisions while starting his postdoc. I'm going to try my first thread (1/9) h

RT @Surbhi__Sood: Defining the role of GBAF dependencies in prostate cancer. Amazing work from @EmilyDykhuizen lead by Aktan Alpsoy !!

Defining the role of GBAF dependencies in prostate cancer. Amazing work from @EmilyDykhuizen lead by Aktan Alpsoy !!

BRD9 is a critical regulator of androgen receptor signaling and prostate cancer progression from @EmilyDykhuizen https://t.co/jkfsiLh7MD https://t.co/UxsIjCBGw8

BRD9 is a critical regulator of androgen receptor signaling and prostate cancer progression. https://t.co/cjDzwdj6Ej https://t.co/l79neydqZy

BRD9 is a critical regulator of androgen receptor signaling and prostate cancer progression.: Related Articles BRD9 is a critical regulator of androgen receptor signaling and prostate cancer progression. Cancer Res. 2020 Dec 21;: Authors: Alpsoy A,… https:

BRD9 is a critical regulator of androgen receptor signaling and prostate cancer progression. https://t.co/UWfy0CCBFx

New article: BRD9 is a critical regulator of androgen receptor signaling and prostate cancer progression. https://t.co/5d60ryvtYw #prostatecancer #oncology https://t.co/h5EIfcxJ0V